Steven M. Albelda

Scientific Founder at Capstan Therapeutics

Steven M. Albelda, M.D., is the William Maul Measey Professor of Medicine, Director of the Thoracic Oncology Research Laboratory, and co-Director of the Translational Center of Excellence for Lung Cancer. Dr. Albelda has led an NCI-funded Program Project aimed at developing immune-gene therapy for thoracic cancers for the past 22 years, resulting in a series of Phase 1 and 2 clinical trials for patients with mesothelioma and lung cancer. The major areas of recent interest in the lab have been augmentation of anti-tumor immune effects, adoptive T cell transfer, and characterization and modulation of the tumor microenvironment.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Capstan Therapeutics

2 followers

Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.


Employees

1-10

Links